Wilms tumour 1 peptide vaccine as a cure‐oriented post‐chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse
暂无分享,去创建一个
N. Hosen | Y. Oji | M. Kawakami | A. Tsuboi | Y. Oka | H. Sugiyama | D. Motooka | A. Kumanogoh | J. Nakata | K. Hasegawa | S. Nishida | F. Fujiki | H. Nakajima | S. Morimoto | Y. Nakae